π Compass Pathways
Compass Pathways is a biopharmaceutical company developing psilocybin-based therapies for treatment-resistant depression and other mental health conditions, operating within the emerging psychedelic medicine industry under regulatory frameworks monitored by global health and drug policy intelligence agencies.
8
Signals
7
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| How one family gave a critical boost to gene therapy research | expired | Health | involved | 100% | |
| Compass Pathways stock maintained at Buy by TD Cowen ahead of NDA filing | expired | Health | involved | 56% | |
| NFL, Eagles Defend Handling of Jalen Hurtsβs Blood Clots | expired | Health | responder | 100% | |
| Common cold sore virus may reprogram the brain's immune defenses | expired | Health | involved | 100% | |
| Newcastle Joins Premier League Race for β¬65 Million Brentford Defender | expired | Deals | involved | 100% | |
| Outrage grows as CDC reportedly poised to fund "unethical" vaccine trial | expired | Health | involved | 100% | |
| STAT+: Bristol Myers Squibb partners with Chinaβs Hengrui Pharma on a dozen drugs | expired | Health | involved | 100% | |
| U.S. Army buys more Israeli SMASH counter-drone rifle system | expired | Deals | involved | 100% |